Freeman Mason 4
4 · CinCor Pharma, Inc. · Filed Jan 13, 2022
Insider Transaction Report
Form 4
Freeman Mason
EVP Clinical Development
Transactions
- Purchase
Common Stock
2022-01-11$16.00/sh+2,500$40,000→ 2,500 total - Purchase
Common Stock
2022-01-11$16.00/sh+100$1,600→ 100 total(indirect: By Spouse)
Footnotes (1)
- [F1]The securities are held by the Reporting Person's spouse. The Reporting Person shares voting and investment control of the shares and may be deemed to beneficially own the shares. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his proportionate pecuniary interest therein.